American Precision Biotechnology focuses on the research, development, production, and sales of early cancer screening and home-based self-testing technologies. The company has established an
integrated platform for R&D, testing, and production, and has successfully developed the world’s
first next-generation rapid home self-testing technology for cervical cancer and colorectal cancer, filling a global gap in home-based cancer self-testing.
• Headquartered in the United States, the company has subsidiaries in Hong Kong and Tianjin, China, with its R&D and production center located in Seattle, Washington. The team is highly experienced
and specialized.
• The company’s products include a range of early cancer home self-testing kits and fully automated chemiluminescence immunoassay analyzers. For example, the cervical cancer E7 protein home
self-testing kit can directly detect the E7 cancer protein produced by cancer cells. Compared to traditional cervical cancer screening methods, this technology offers significant advantages.
Comments (0)